Delivery Order SPE2DB22D1002-SPE2DB24FLHA9
Award Date
8/26/24
Potential Completion Date
9/17/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $4,711.62 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of PROQUAD VIALS, a vaccine product, with a period of performance through July 5, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a $16,019.90 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide....
The Defense Logistics Agency (DLA) awarded a $14,134.86 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of PROQUAD VIALS. This contract has no set-aside designation and is scheduled for completion by September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medical supplies to support various government agencies and healthcare programs. The company has been awarded numerous federal contracts by the DLA and...
This is a $2,507.55 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to supply PROQUAD VIALS. The award has an ultimate completion date of August 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued up to $16,019.90 to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This Firm Fixed Price contract is for the supply of PROQUAD VIALS and has a period of performance through May 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for PROQUAD VIALS, a medical supply, with a firm fixed price ceiling value of $1,601.99. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp for the supply of PROQUAD VIALS. The $1,570.54 firm fixed-price contract has an ultimate completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these medical supplies to support federal healthcare programs and services. The contract is not set aside for any socioeconomic category. Amerisourcebergen holds several Indefinite Delivery Contracts...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,711.62, is for the delivery of PROQUAD VIALS medical supplies. The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The Defense Logistics Agency awarded a $11,930.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. This contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...